Dr. Shaojun Lin 林少俊
Chief Physician
Department of Radiation Oncology, Fujian Cancer Hospital, Fuzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radiation oncology with a focus on head and neck tumors, particularly the diagnosis and treatment of nasopharyngeal carcinoma.
Dr. Lin graduated from Shanghai Medical University in 1988 and completed advanced training at Institut Curie, France (2003–2004). As Chief Physician and Administrative Director of Ward 18, Dr. Lin specializes in radiation therapy for head and neck tumors. Dr. Lin has published over 30 papers, contributed to three national textbooks, and led one Fujian medical innovation project.
Professional roles
- Member, Nasopharyngeal Carcinoma Professional Committee, China Anti-Cancer Association
- Secretary, Chinese Nasopharyngeal Carcinoma Staging Committee
- Vice Chair, Nasopharyngeal Carcinoma Professional Committee, Fujian Anti-Cancer Association
- Member, Oncology Radiotherapy Society, Fujian Medical Association
Name order: in Chinese the family name comes first (Lin Shaojun). Papers usually list the name as Shaojun Lin or Lin S.
Selected publications
79 papers on PubMed matched by name and affiliation; 16 as first or senior author since 2016. Most recent first- or senior-author papers:
- Head Neck, 2026 (senior author): Appraisal of Radiologic Size Criteria for Malignant Lymph Nodes in Parotid Region in Nasopharyngeal Carcinoma: Implication for Parotid-Sparing IMRT. PubMed 41358506
- Int J Radiat Oncol Biol Phys, 2025 (first author): International Consensus Guideline on Delineation of the Clinical Target Volumes at Different Dose Levels for Nasopharyngeal Carcinoma (2024 Version). PubMed 40419028
- Int J Radiat Oncol Biol Phys, 2025 (senior author): Long-Term Outcome in Cervical Lymph Node-Positive Nasopharyngeal Carcinoma Following Intensity Modulated Radiation Therapy With One-Step Cervical Nodal Clinical Target Volume Delineation by Geometric-Anatomic Expansion From Nodal Gross Target Volume: A Double-Center Experience. PubMed 39674327
- Eur J Cancer, 2024 (senior author): 5-Hydroxymethylcytosines in circulating cell-free DNA as a diagnostic biomarker for nasopharyngeal carcinoma. PubMed 39213787
- Radiother Oncol, 2024 (senior author): Selectively sparing of the supraclavicular area during intensity-modulated radiotherapy in nasopharyngeal carcinoma: A double-center observation study. PubMed 38184146
- Curr Oncol, 2023 (senior author): Effect of Percutaneous Endoscopic Gastrostomy on Quality of Life after Chemoradiation for Locally Advanced Nasopharyngeal Carcinoma: A Cross-Sectional Study. PubMed 36661725
- Oral Oncol, 2022 (senior author): Plasma Epstein-Barr viral DNA load after completion of two cycles of induction chemotherapy predicts outcomes for patients with advanced-stage nasopharyngeal carcinoma. PubMed 35728415
- Asia Pac J Clin Oncol, 2022 (senior author): Re-evaluation of the prognostic significance of retropharyngeal node metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy. PubMed 34541812
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion